FDA approves Immucor’s PreciseType® HEA Test to be used for screening blood donors for Sickle Cell Trait (SCT)
21 oct. 2016 17h10 HE
|
Immucor, Inc.
Now recognized as a tool to identify SCT negative units in addition to extended antigen typings all in one test Reduces the time and expense of selecting units for patients requiring frequent...
Immucor to Host Debt Investor Conference Call on Friday, October 21, 2016
17 oct. 2016 17h41 HE
|
Immucor, Inc.
NORCROSS, Ga., Oct. 17, 2016 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that it will hold a conference call with debt...
Immucor to Host Debt Investor Conference Call on Wednesday, September 7, 2016
22 août 2016 17h04 HE
|
Immucor, Inc.
NORCROSS, Ga., Aug. 22, 2016 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that it will hold a conference call with debt...
Immucor Announces the Launch of kSORT™ to Support the Health of Kidney Transplant Recipients
02 mai 2016 14h18 HE
|
Immucor, Inc.
NORCROSS, Ga., May 02, 2016 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, announced today the launch of its kidney Solid Organ Response Test,...
Immucor to Host Debt Investor Conference Call on Thursday, April 21, 2016
13 avr. 2016 09h19 HE
|
Immucor, Inc.
NORCROSS, Ga., April 13, 2016 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that it will hold a conference call with debt...
Medicare Administrative Contractors Finalize Local Coverage Determinations for Immucor PreciseType® HEA Test
04 avr. 2016 16h08 HE
|
Immucor, Inc.
NORCROSS, Ga., April 04, 2016 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, announced that Medicare Administrative Contractors (MACs) that...
Immucor’s ImmuLINK® Software Suite v1.7 Receives FDA Clearance to Interface with PreciseType™ HEA
21 mars 2016 15h52 HE
|
Immucor, Inc.
NORCROSS, Ga., March 21, 2016 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced FDA clearance for the latest release of ImmuLINK®...
Immucor Acquires Sirona Genomics
04 mars 2016 17h08 HE
|
Immucor, Inc.
Transaction culminates successful collaboration to bring MIA FORA™ NGS offering for high resolution HLA typing to market NORCROSS, Ga., March 04, 2016 (GLOBE NEWSWIRE) -- Immucor, Inc., a global...
Immucor and Sirona Genomics Announce CE Mark for MIA FORA™ NGS HLA Typing Solution
03 févr. 2016 11h41 HE
|
Immucor, Inc.
NORCROSS, Ga., Feb. 03, 2016 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, in collaboration with Sirona Genomics, today announced CE Mark...
Immucor to Host Debt Investor Conference Call on Tuesday, February 2, 2016
14 janv. 2016 17h28 HE
|
Immucor, Inc.
NORCROSS, Ga., Jan. 14, 2016 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that it will hold a conference call with debt...